It. Beck et al., INSURANCE RATING OF PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - REPORTOF A CONFERENCE ON MORBIDITY AND MORTALITY, Canadian journal of gastroenterology, 8(7), 1994, pp. 438-445
Patient members reported to the Crohn's and Colitis Foundation of Cana
da (CCFC) about their difficulties to obtain insurance. In 1991, the L
ay Board of the CCFC requested its Medical Advisory Board (MAB) to inv
estigate this problem. At that time, insurance ratings could be illust
rated by the 1985 edition of Brackenridge's monograph on life risks. T
he MAB found that data on mortality were outdated. A conference on mor
bidity and mortality of inflammatory bowel disease (IBD) was organized
by the authors and held in May 1992. Based on questionnaires to patie
nts, evidence provided by invited speakers and the results of small gr
oup conferences, it was concluded that patients with IBD have difficul
ties in obtaining insurance, even though the quality of life and morta
lity of IBD patients is not very different from that of the general po
pulation. However, the mortality rate of the healthy insured populatio
n is lower than that of the general population, and thus much lower th
an that of IBD patients. Patients have a better chance to obtain insur
ance if there is a close cooperation between the treating physician an
d the medical officer of the insurance company. Changes have occurred
since the conference held in May 1992. The recent edition of Brackenri
dge's text (1992) provides a better prognosis but unfortunately unchan
ged rating for patients with IBD than did the 1985 edition. Close coop
eration between the Patient Advisory Committee of the CCFC and the Exe
cutives of the Canadian Life Insurance Medical Officers Association ma
y further improve the insurance rating of patients with IBD.